Studying health consequences of microchimerism: Methodological problems in studying health effects of procreation with multiple partners

European Journal of Epidemiology

Volumn 18, Issue 7, 2003, Pages 623-630

  Olsen, Jørn ^a   Campi, Rita ^a,b   Frydenberg, Morten ^c   Basso, Olga ^a   Ebbesen, Peter ^d  

^a UNIVERSITY OF AARHUS   (Denmark)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c AARHUS UNIVERSITY   (Denmark)

^d AALBORG UNIVERSITY   (Denmark)

Author keywords

Methods; Microchimerism; Mortality; Multiple partners

Indexed keywords

ADULT; ARTICLE; DENMARK; FEMALE; FERTILITY; HEALTH HAZARD; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MATERNAL WELFARE; MICROCHIMERISM; MORTALITY; PARITY; PREGNANCY; SEXUAL BEHAVIOR; SOCIAL ASPECT;

EID: 0042021763     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024899612055     Document Type: Article

References (17)

1. Wohlfahrt J, Andersen PK, Mouridsen HT, Adami H-O, Melbye M. Reproductive history and stage of breast cancer. Am J Epidemiol 1999; 150: 1325-1330.
2. Nelson JL. Microchimerism: Expanding new horizon in human health or incidental remnant of pregnancy? Lancet 2001; 358: 2011-2012.
3. Srivatsa B, Srivatsa S, Johnson KL, Samura O, Lee SL, Bianchi DW. Microchimerism of presumed fetal origin in thyroid specimens from women: A case-control study. Lancet 2001; 358: 2034-2038.
4. Janerich DT. Pregnancy, breast-cancer risk, and maternal-fetal genetics (letter). Lancet 1969; 1: 1240-1241.
5. Janerich DT. The influence of pregnancy on breast cancer risk: Is it endocrinological or immunological? Med Hypotheses 1980; 6: 1149-1155.
6. Janerich DT. The fetal antigen hypothesis for breast cancer, revisited. Med Hypotheses 1994; 43: 105-110.
7. Gafter U, Sredni B, Segal J, Kalechman Y. Suppressed cell-mediated immunity and monocyte and natural killer cell activity following allogeneic immunization of women with spontaneous recurrent abortion. J Clin Immunol 1997; 17: 408-419.
8. Famularo G, de Simone C. Systemic sclerosis from autoimmunity to alloimmunity. South Med J 1999; 92: 472-476.
9. Scradavou A, Carrier C, Mollen N, Stevens C, Rubinstein P. Detection of maternal DNA in placental/umbilical cord blood by locus-specific amplification of the noninherited maternal HLA gene. Blood 1996; 88: 1494-1500.
10. Kaye DH, Vyvial TM, Young D. Validating the probability of paternity. Transfusion 1991; 31: 823-828.
11. Scaletti C, Vultaggio A, Bonifacio S, et al. Th2-oriented profile of male offspring T cells present in women with systemic sclerosis and reactive with maternal major histocompatibility complex antigens. Arthritis Rheum 2002; 46: 445-450.
12. Sevost'ianova OIu, Teplova SN, Cherdantseva GA, et al. Characteristics of the population and subpopulation composition of peripheral blood lymphocytes in noncomplicated pregnancy based on flow cytofluorometry data. Zh Mikrobiol Epidemiol Immunobiol 2001; 4: 97-100.
13. Mahmoud F, Abul H, Omu A, Al-Rayes S, Haines D, Whaley K. Pregnancy-associated changes in peripheral blood lymphocyt subpopulations in normal Kuwaiti women. Gynecol Obstet Invest 2001; 52: 232-236.
14. Whitacre CC, Reingold SC, O'Looney PA. The Task Force on Gender, Multiple Sclerosis and Autoimmunity. Science 1999; 283: 1277-1278.
15. Janerich DT, Thompson WD. Reduced breast cancer risk after remarriage: Evidence of genetic-immune protection. Epidemiology 1995; 6: 254-257.
16. Janerich DT, Hoff MB. Evidence for a crossover in breast cancer risk factors. Am J Epidemiol 1982; 116: 737-742.
17. Skinner J, Luettich K, Ring M, O'Leary JJ, Turner MJ. Fetal DNA in Maternal Circulation of First-Trimester Spontaneous Abortions. Obstet Gynecol 2001; 97: 460-463.